PoliTalker
Diversity Makes Greatness
5 good reasons for the FDA to give full approval to COVID-19 vaccines: Analysis
" As early as this coming week, according to The New York Times, the U.S. Food and Drug Administration is expected to give full approval to Pfizer-BioNTech's coronavirus vaccine -- the first COVID-19 vaccine expected to receive that endorsement.
The FDA's approval might seem like a minor technical move to some. But full approval of all three COVID-19 vaccines is an important step that can make a difference in reducing COVID-19 infection and mortality rates, improving health care delivery and saving lives.
Here's why:
1. The approval will empower health care professionals to address the myth of "experimental vaccines."
2. Approval of the vaccines will get more kids vaccinated.
3. Approval will provide us with longer-term safety data.
4. Approval will provide employers with greater authority to mandate vaccines.
5. Approval will allow the prescribing of vaccines for "off-label" use."
" As early as this coming week, according to The New York Times, the U.S. Food and Drug Administration is expected to give full approval to Pfizer-BioNTech's coronavirus vaccine -- the first COVID-19 vaccine expected to receive that endorsement.
The FDA's approval might seem like a minor technical move to some. But full approval of all three COVID-19 vaccines is an important step that can make a difference in reducing COVID-19 infection and mortality rates, improving health care delivery and saving lives.
Here's why:
1. The approval will empower health care professionals to address the myth of "experimental vaccines."
2. Approval of the vaccines will get more kids vaccinated.
3. Approval will provide us with longer-term safety data.
4. Approval will provide employers with greater authority to mandate vaccines.
5. Approval will allow the prescribing of vaccines for "off-label" use."